Objective: Aortitis is an exceedingly rare manifestation of tuberculosis. We describe 11 patients with tuberculous aortitis (TA).
Tuberculous aortitis (TA) stands as a rare but severe manifestation of tuberculosis. In a series of 100 autopsy cases with generalized tuberculosis, only one had TA. 1 In the same line, the major clinical study in the field showed that only 41 cases have been reported in the English-language medical literature between 1945 and 1999. 2 Infection of the aorta by Mycobacterium tuberculosis usually appears as the direct extension from a contiguous infection (ie, tuberculous lymphadenitis) that leads to the formation of an aortic pseudoaneurysm, in most cases affecting the thoracic and abdominal aorta equally. 2 A combination of surgical intervention and prolonged antibiotherapy is warranted for disease-free, long-term survival. We describe 11 patients diagnosed with TA between April 2003 and December 2015 in France with new insights on such an exceedingly rare form of extrapulmonary tuberculosis.
METHODS
Patients. We conducted a retrospective multicenter study of adult patients hospitalized during a 12-year period ( aneurysm, ectasia, dilation, stenosis, or occlusion of the aorta and its branches or periaortic soft tissue changes by computed tomography (CT) angiography 3 and (2) inflammatory changes of the aortic wall according to pathologic analysis when surgery was performed. 4 Tuberculosis disease was defined as active according to current diagnostic and classification criteria. 5 The date of TA diagnosis was arbitrarily defined as the first day of antituberculosis treatment.
Patients hospitalized during the same period for tuberculosis disease without aortitis were also analyzed as a control series. The International Classification of Diseases, Tenth Revision codes for tuberculosis disease (A150, A151, A156, A158, A159, A160, A161, A162, A163, A165, A167, A168, A169, A170, A180, A181, A182, A183, A184, A185, A188, A199) were used for screening of patients. Data were extracted from the French diagnosis-related groupsbased information system (PMSI) databases.
Data collection. Demographic, medical history, laboratory, imaging, pathologic findings, treatment, and follow-up data were extracted from medical records. Descriptive statistics included the mean (standard deviation) or median (minimum-maximum) as appropriate for continuous variables and frequency (percentage) for categorical variables.
Ethical statement. Our study is a retrospective human noninterventional study. According to the Public Health French Law (articles L 1121-1-1 and L 1121-1-2), approval from an Institutional Review Board and written consent are not required for human noninterventional studies. For ethical consideration, however, patients were informed that data collected in medical records might be used for research study in accordance with the privacy rule. The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki.
RESULTS
Characteristics of patients. Eighteen patients were identified between 2003 and 2015. Seven patients were excluded because diagnosis criteria for TA were not met (n ¼ 4) or data were missing (n ¼ 3). Patients who did not meet diagnosis criteria for TA had aortitis due to Mycobacterium bovis after bacille Calmette-Guérin treatment for bladder cancer (n ¼ 1), typical atherosclerotic aneurysm with a past history of cured tuberculosis (n ¼ 1), and Takayasu arteritis involving aortic tributaries associated with a positive test result of QuantiFERON-TB Gold (Quest Diagnostics, Madison, NJ) as the only clue for tuberculosis (n ¼ 2). Eleven patients (8 women) were eventually studied.
The median age at TA diagnosis was 44.6 years (16-75 years). All but one patient had lived in tuberculosis endemic countries: Congo, Ivory Coast, Haiti, Guinea, Madagascar, former Yugoslavia, Morocco, and Algeria. No patient had human immunodeficiency virus infection. Five patients suffered underlying comorbid conditions including diabetes (n ¼ 2), cirrhosis (n ¼ 1), chronic kidney disease (n ¼ 1), and inflammatory colitis (n ¼ 1). The median delay between the onset of the first symptom and TA diagnosis was 18 (0-36) months.
At disease onset, patients reported weight loss (
. Five patients presented with upper limb (n ¼ 1) or lower limb (n ¼ 4) claudication. At physical examination, vascular findings were asymmetric blood pressure (n ¼ 3), diminished or absent pulse in the lower limbs (n ¼ 3), and pulsatile cervical mass (n ¼ 1). Other features included swollen lymph nodes (n ¼ 6), nodular erythematous eruption of the lower legs (n ¼ 4), and uveitis (n ¼ 1). Blood C-reactive protein levels were raised in eight (of nine tested) patients (median, 50 mg/L ; Table I ).
Diagnosis of TA. Tuberculosis was active in all cases. The diagnosis of tuberculosis was suspected because of clinical presentation at disease onset and chest CT scan findings including enlarged or necrotic mediastinal lymph nodes (n ¼ 3), nodular opacities (n ¼ 2), diffuse miliary opacities (n ¼ 1), and pleuritis (n ¼ 1). Of note, findings on chest CT scan were normal in 5 patients.
The QuantiFERON-TB Gold test was performed in seven patients and the result was positive in five. The tuberculin skin test response was always positive when it was performed (n ¼ 7).
Aortic CT angiography displayed aortic pseudoaneurysm (n ¼ 7) but also aortic stenosis (n ¼ 2; Fig 1) . The size of the pseudoaneurysms ranged from 20 to 84 mm. An increased segmental thickening of the aorta wall thickness was seen in all but two cases. Isolated aortic thoracic lesions, in either the ascending (n ¼ 2) or descending (n ¼ 2) thoracic aorta, were observed in four cases. Isolated abdominal aortitis was found in two patients. Panaortic (ie, both thoracic and abdominal aorta) lesions were observed in five cases. Aortic primary tributaries including subclavian (n ¼ 3) and iliac (n ¼ 1) arteries were involved in four patients. Aortic lesions appeared contiguous to lymph node involvement in three patients only. Aorta specimens were obtained during surgery in eight cases. At surgery, periaortic inflammation was obvious in only one patient. On microscopic examination, prominent fibrosis was observed in adventitial layers (n ¼ 8) and associated with atrophy of the media in all but one case (Fig 2) . Aortic wall was infiltrated with mononuclear cells (n ¼ 6), multinuclear giant cells (n ¼ 5), or plasma cells (n ¼ 3). Tuberculoid granulomas were seen in the arterial specimen in five cases. Besides vascular samples, necrotizing granulomas were also observed in lymph nodes (n ¼ 5) and dermis (n ¼ 1). Ziehl-Neelsen staining was negative on all samples. M. tuberculosis identification by culture or polymerase chain reaction was made in three patients only, in lymph nodes (n ¼ 2) and aorta (n ¼ 1). Sputum cultures were negative in all cases. Details are given in Table II. Compared with the 105 patients admitted for tuberculosis without aortitis in our department (Internal Medicine, Bichat Hospital, Paris) during the same period, patients with TA were more frequently women (P ¼ .043) and had more frequently associated comorbidity (P ¼ .033), such as diabetes and chronic inflammatory disorders requiring long-term steroids or immunosuppressive drugs (Table III) .
ARTICLE HIGHLIGHTS
Treatment. All patients received oral treatment, which consisted of isoniazid, rifampin, pyrazinamide, and ethambutol for 2 months, followed by rifampin and isoniazid for an additional 4 to 10 months.
Surgery was performed at once in eight patients. Indications for surgery were aortic (n ¼ 7) or subclavian artery (n ¼ 1) aneurysms. Two cases required an emergency procedure because of the size of the aneurysm (84 mm) or signs of impending rupture (intense abdominal pain). Bentall procedures (n ¼ 2), aortic bypass (n ¼ 1), and open (n ¼ 5) abdominal aneurysm repair were performed. Omentum flap-wrapped prosthetic grafts (n ¼ 3) or cryopreserved arterial allografts (n ¼ 2) were used for aneurysm reconstruction. The median length of antibiotic treatment after surgery was 7 (7-12) months.
Five patients received steroid therapy initiated at the time of antituberculosis treatment for at least 6 weeks. The steroid daily dose at start ranged from 0.25 mg/kg to 2 mg/kg. Steroids were given to patients displaying symptoms (such as claudication) associated with stenosis or periaortic soft tissue changes due to mural thickening of the aorta and its branches.
Outcome. All patients clinically improved under treatment. No patients died during a median follow-up of 4 years (1-11 years). Aortic CT angiography follow-up was available for eight patients. In four patients, CT angiography displayed improvement (n ¼ 2) or stabilization (n ¼ 2) of aortic lesions. Despite antituberculosis treatment, worsening of previously known lesions was observed in four patients, including aneurysm (n ¼ 1) and aortic stenosis with periaortitis (n ¼ 3). Of note, no aortic lesion aggravation was observed in three (of four) patients who received steroids at time of TA diagnosis, Comorbid conditions refer to diabetes (n ¼ 9), chronic inflammatory disorders requiring long-term steroid or immunosuppressive drugs (n ¼ 8), chronic kidney or cardiac disease (n ¼ 3), cancer (n ¼ 2), and cirrhosis (n ¼ 2). The Mann-Whitney test was used to compare continuous variables. The Fisher exact test was used to compare dichotomous variables.
whereas worsening occurred in three (of four) patients in whom steroids were not given at TA diagnosis. Further surgery was required in two more patients for stenosis involving brachial arteries (n ¼ 1) and aortic aneurysm (n ¼ 1) between 6 and 18 months after TA diagnosis. Besides surgery, steroids were given in both cases for up to 3 years, associated with methotrexate in one patient. No cases of graft infection with M. tuberculosis were observed.
DISCUSSION
Our retrospective case series highlights several salient features regarding diagnosis and treatment of TA. TA remains a rare disease. From 2003 to 2015, 86 patients with aortitis were admitted in our sole department (Internal Medicine, Bichat Hospital, Paris). Among them, 36 had Takayasu disease, 34 had an aortitis associated with giant cells arteritis, 11 had an infectious aortitis (including 3 with TA), and 5 had an unclassified inflammatory aortitis. Overall, aortitis was due to tuberculosis infection in 3.5% of cases. In the meantime, 108 patients were admitted for tuberculosis infection in our department, meaning that tuberculosis infection was complicated by aortitis in 2.8%.
TA diagnosis is challenging, with a median delay of 18 months between the first symptom and the start of antituberculosis therapy. Constitutional symptoms (ie, fever, night sweats, and weight loss), swollen lymph nodes, nodular skin eruption, and uveitis were always present to some degree in our patients. Of note, M. tuberculosis identification or evidence for specific pathologic features, such as necrotizing granulomas, could be obtained from lymph nodes or skin specimen without proceeding to aorta biopsy for diagnostic purposes.
M. tuberculosis identification was lacking in most of our cases. A high index of suspicion for TA is usually based on clinical features and histologic analysis results, such as inflammation with multinuclear giant cell reaction and fibrotic lesions. 4 Failure to isolate M. tuberculosis may have resulted from a low bacillary burden in lowoxygen extrapulmonary tissues or errors in specimen processing and does not exclude active tuberculosis. [5] [6] [7] [8] [9] Our patients improved on antituberculosis treatment. Of note, no alternative diagnosis emerged despite extensive workup and a prolonged follow-up of 4 years. Compared with tuberculosis disease without aortitis, diagnosis of TA was more frequently based on the presence of tuberculosis granuloma than on the formal M. tuberculosis identification (Table III) . Although aortic pseudoaneurysm is the most common vascular pattern of TA, 2,10 we observed isolated increased aortic wall thickness and arterial stenosis. Interestingly, a recent study identified a high frequency of M. tuberculosis and M. bovis genes in aortic tissues of Takayasu patients, 11 supporting the hypothesis that M. tuberculosis plays a role in the immunopathogenesis of Takayasu arteritis. 12 Tuberculous pseudoaneurysm may lead to aortic rupture and requires in all cases aortic bypass grafting in addition to antituberculosis therapy. 2, 10, 13 In our series, open surgery was promptly performed in all cases of pseudoaneurysm because of the size of the pseudoaneurysm, the unpredictable risk of rupture in such a context, and the need for excision and débridement of the infected field. Although attractive as a temporizing measure, no endovascular aneurysm repair was performed. On the other hand, in case of inflammatory stenotic lesions, surgery was not systematically performed. Indeed, first-line antituberculosis quadritherapy followed by adjuvant steroid treatment without a vascular procedure has led to disease remission in three patients. Our data challenge the contiguity hypothesis that the aortic wall is always involved directly by an adjacent tuberculous process, such as lymphadenitis. 2 In our series, TA resulted from direct extension from a contiguous infection in only three cases. In the other patients, infection of the aorta may have resulted from bloodborne bacilli, either by way of the vasa vasorum of the aorta or directly by implantation on the intima. 2 Our study suggests that early start of steroids may be useful. The current duration of antibiotic treatment for all adults with extrapulmonary tuberculosis is at least 6 months.
14 Besides antituberculosis therapy, some patients in our series received steroid therapy that was started at the time of TA diagnosis to reduce aortic wall inflammation and thickness. Although controversial, our data are consistent with a systematic review and meta-analysis suggesting that steroids are effective in reducing mortality for all forms of tuberculosis. 15 Our study has obvious limitations that prevent the generalizability of these results. The number of patients studied is small because of the rarity of this condition. The retrospective chart analysis and design may have led to bias.
CONCLUSIONS
TA is no longer a lethal condition. Aortitis may result in aneurysms contiguous to regional adenitis but may also cause isolated inflammatory aortic stenosis. Antituberculosis treatment should be associated with steroids in case of inflammatory stenotic lesions. Surgery is not warranted in all cases but is still indicated for aneurysms and in case of worsening stenotic lesions despite antiinflammatory drugs. 
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